20 July,2024 08:59 PM IST | Mumbai | IANS
Image for representational purposes only. Photo Courtesy: iStock
An international team of researchers conducted a mice study that showed that targeting the production of a key inflammatory protein can extend lifespan, and reduce old age-related diseases.
The team from the Medical Research Council Laboratory of Medical Science (MRC LMS), Imperial College London in the UK, and Duke-NUS Medical School in Singapore investigated the effects of inflammatory proteins IL-11 by generating mice with the IL-11 (interleukin 11) gene removed.
This increased the mice's lifespan by more than 20 per cent on average, revealed the study, published in the journal Nature.
They also gave 75-week-old mice, equivalent to around 55 years in humans, an injection of an anti-IL-11 antibody, a medicine that inhibits the effects of IL-11 in the body.
ALSO READ
Flu virus can remain infectious in refrigerated raw milk for five days: Study
Targeting gut cells may open new way to reduce depression and anxiety
Every 10 unit rise in annual PM2.5 exposure raising death risk in Indians: Study
Early-onset colon cancer cases surge globally but lowest in India: Study
Mumbai doctors give Jalgaon woman with rare heart defect second chance at life
Mice treated with an anti-IL-11 drug from 75 weeks of age had their median lifespan extended by 22.4 percent in males and 25 percent in females, with an average lifespan of 155 weeks compared to 120 weeks in untreated mice.
The treatment reduced cancer deaths, fibrosis, chronic inflammation and poor metabolism, with minimal side effects.
Professor Stuart Cook highlighted the potential for similar effects in humans, stating, "The treated mice had fewer cancers and were free from the usual signs of ageing and frailty."
This research, though conducted in mice, opens possibilities for extending healthy ageing in humans.
Also read: Cinematic monsoon wedding: Expert tips from celebrity videographers
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
